Clinical Trial Update: The VALVE-AI Trial [NA]

View source ↗

Summary

The VALVE-AI trial is currently recruiting for valvular heart disease patients, sponsored by the National Defense Medical Center in Taiwan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Valvular Heart Disease

Snippet

Sponsor: National Defense Medical Center, Taiwan | Conditions: Valvular Heart Disease Patients | NA | Status: RECRUITING